These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences. Levine JP J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729 [No Abstract] [Full Text] [Related]
4. Bleeding problems and progestogen-only contraception. Porter C; Rees MC J Fam Plann Reprod Health Care; 2002 Oct; 28(4):178-81. PubMed ID: 12419054 [No Abstract] [Full Text] [Related]
5. Implantable contraceptives for women. Meirik O Contraception; 2002 Jan; 65(1):1-2. PubMed ID: 11861048 [No Abstract] [Full Text] [Related]
6. Hormonal contraceptives and the risk of cancer. Holck S World Health Stat Q; 1987; 40(3):225-32. PubMed ID: 3687058 [No Abstract] [Full Text] [Related]
7. [Contraceptive injection Depo-Provera, effect on bones and teenage girls]. Edgardh K Tidsskr Nor Laegeforen; 2002 Dec; 122(30):2909-11. PubMed ID: 12569721 [No Abstract] [Full Text] [Related]
8. Progestogens for contraception. Fraser IS Aust Fam Physician; 1988 Oct; 17(10):882-5. PubMed ID: 2977095 [No Abstract] [Full Text] [Related]
9. Hormonal contraception and bone metabolism: a systematic review. Nappi C; Bifulco G; Tommaselli GA; Gargano V; Di Carlo C Contraception; 2012 Dec; 86(6):606-21. PubMed ID: 22717184 [TBL] [Abstract][Full Text] [Related]
10. Progestogen-only contraceptives and cancer risk. La Vecchia C; Franceschi S Eur J Cancer Prev; 2002 Apr; 11(2):113-5. PubMed ID: 11984127 [No Abstract] [Full Text] [Related]
14. The use of long-acting contraceptives in adolescents. Harel Z; Cromer B Pediatr Clin North Am; 1999 Aug; 46(4):719-32. PubMed ID: 10494253 [TBL] [Abstract][Full Text] [Related]
15. Cytological studies in women using different types of hormonal contraceptives. Engineer AD; Misra JS; Tandon P J Indian Med Assoc; 1980 Mar; 74(5):88-91. PubMed ID: 7410860 [TBL] [Abstract][Full Text] [Related]
17. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents]. Gambini G; Farina G; Arbosti G Med Lav; 1976; 67(2):152-7. PubMed ID: 1021708 [No Abstract] [Full Text] [Related]
18. [Hormonal contraception and cancer risk]. Ebeling K; Göretzlehner G Z Arztl Fortbild (Jena); 1985; 79(9):365-7. PubMed ID: 4024671 [No Abstract] [Full Text] [Related]
19. Breast Cancer Risk with Progestin Subdermal Implants: A Challenge in Patients Counseling. Mohammed G; Mousa NA; Talaat IM; Ibrahim H; Saber-Ayad M Front Endocrinol (Lausanne); 2021; 12():781066. PubMed ID: 34975755 [TBL] [Abstract][Full Text] [Related]